Hangzhou Jiuyuan Genetic Biopharmaceutical (02566) published its monthly return for the period ended 31 October 2025. The registered share capital remained at RMB 245,398,800, comprising 109,096,785 H shares, 105,302,015 domestic shares, and 31,000,000 unlisted foreign shares. No variations in the number of issued shares or treasury shares were reported, and there were no outstanding share options, warrants, or other convertible securities during the period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.